Insights On Enterprise Solutions
-
Innovation, Driven By Need: An Engineer's Perspective
9/3/2026
Learn how repeated mechanical stress can affect fluid-transfer reliability, as well as why tubing performance is an important consideration for maintaining process continuity.
-
FUJIFILM Biotechnologies Capabilities Update August 2026: CPHI Special Edition
9/3/2026
Join George Sakellariou, Vice President, Global Account Management to learn how FUJIFILM Biotechnologies’ recent investments across its global CDMO network are helping customers accelerate development, reduce risk, and support commercial success.
-
Scaling Down For Success: Optimizing Single-Use Virus Filtration For Small-Scale Bioprocessing
9/2/2026
Automation can bring greater consistency, product recovery, data capture, and operational efficiency to small-scale viral filtration once processes are sufficiently defined, helping gene therapy developers transition beyond highly manual workflows.
-
Simtra Biopharma Solutions Capabilities Update August 2026: CPHI Special Edition
9/2/2026
Discover how strategic investments, advanced fill-finish capabilities, and flexible manufacturing models are helping meet growing demand for sterile drug production and long-term scalability.
-
A New Chapter Begins At Our Sondo Bio Campus
9/2/2026
Built for large-scale biologics manufacturing, the Songdo Bio Campus combines 120KL capacity, advanced bioreactor technology, digital operations, and robust quality systems.
-
A Late-Stage QTPP, CQA, And CPP Mapping Guide
9/2/2026
Clear connections among QTPP requirements, CQAs, and CPPs help teams preserve process knowledge. Examine how a structured mapping approach supports stronger risk assessments and documentation.
-
Saving Time And Money With Better Microbial Strain Selection
9/2/2026
Deeper, automated E. coli screening can reduce cell line development costs by narrowing the design space, lowering the marginal cost of additional experiments, and improving downstream productivity through higher titers and cleaner harvests.
-
BE Biosol Capabilities Update August 2026: CPHI Special Edition
9/2/2026
BE BioSol is the biologics CDMO business of Biological E. Limited, combining more than 70 years of biopharmaceutical manufacturing experience with a growing, integrated development and manufacturing platform for global biopharma partners.
-
Cartridge Filling: Where Precision, Process Control, And Experience Matter
9/1/2026
Cartridge drug delivery demands strict controls to guarantee dose accuracy. Early development and testing eliminate variability, prevent defects, and protect patient safety.
-
Understanding How Value by Design Can Bring Your Drug to Market Faster
9/1/2026
See how predictive modeling and Quality by Design help reduce development costs, improve process understanding, and enable more confident decisions.